Managing Multiple Myeloma in the Elderly

Slides:

Advertisements

Similar presentations

2007 ACC/AHA Peri-operative guidelines- Anesthesia’s recommendations

Advertisements

Test practice Multiplication. Multiplication 9x2.

This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.

UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.

Renal Palliative Care in WA Developments & Challenges Dr Brian Siva 21 st August 2015.

Bariatric Surgery: Outcomes and Safety MISS 2010 Bruce M. Wolfe, MD Professor of Surgery Oregon Health & Science University.

A Phase II Study with Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma Bringhen S et al. Proc ASH 2013;Abstract.

Prognostic factors in systemic lupus erithematosus Author: Nicoleta Roman Cooauthor: Anicua-Ionela Morar Coordinator: Lecturer Dr. Monica Copotoiu U.M.F.

TITLE lecturer Institution. Presenter Disclosure Information.

Case 4: 65-year-old Man Newly Diagnosed, Has Other Health Issues Paul E. Sax, MD Clinical Director, Division of Infectious Diseases Brigham and Women’s.

CoRPS Center of Research on Psychology in Somatic diseases Multiple myeloma survivors experience a low quality of life and many disease-specific complaints:

10-1 人生与责任淮安工业园区实验学校连芳芳 “ 自我介绍 ” “ 自我介绍 ” 儿童时期的我.

Sarah Kunin, MD Princeton Baptist Medical Center Baptist Health Systems Alabama Multiple Myeloma: Treatment with Bisphosphonates.

The reading is 7.38 mm. The reading is 7.72 mm.

Bortezomib plus melphalan and prednisole in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study Marı´a-Victoria.

NEUROLOGY SURVEY PRELIMINARY FINDINGS. Diagnosed Conditions of Participants.

Scottish Renal Cancer Forum National Meeting 31st March 2016 Renal cancer survival Period of diagnosis: Roger Black.

Personal Experiences of Progressive Multiple Sclerosis (MS)

Overall Goal. Clinical Conversations: Nursing Care for Patients With Multiple Myeloma.

Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,

Highlights: Myeloma Oral Session

FORTE: Induction With Carfilzomib, Dexamethasone, and Cyclophosphamide or Lenalidomide in Newly Diagnosed MM CCO Independent Conference Highlights* of.

Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World.

Journal of Geriatric Oncology

The Atrial Fibrillation Clinic in Llanelli

Yahoo Mail Customer Support Number

Most Effective Techniques to Park your Manual Transmission Car

How do Power Car Windows Ensure Occupants Safety

End point Patients >75 y with renal insufficiency

Nurses' Toolbox: How to Improve Patient Outcomes in Multiple Myeloma

Please note this program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.

Hot Off the Press: Changes in the Landscape of Multiple Myeloma

SAVE Trial design: Patients with moderate to severe obstructive sleep apnea (OSA) and known CV disease were randomized in a 1:1 fashion to either CPAP.

Selecting MM Therapy in Patients With Comorbidities

Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma.

Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,

The Nurse View: Best Practices in Multiple Myeloma

Nat. Rev. Cardiol. doi: /nrcardio

Advances in Multiple Myeloma

Vesole DH et al. Proc ASH 2010;Abstract 308.

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care.

Advances in Multiple Myeloma: Data Highlights and Analysis from the 2015 Hematology/Oncology Conferences.

Approaches in Newly Diagnosed Multiple Myeloma: When and What

Staying Abreast of Best Practices Across the Clinical Continuum

Figure 1 Translocations involved in multiple myeloma

Building an Outpatient Kidney Palliative Care Clinical Program

Patients who have received chemotherapy (n=60)

Nat. Rev. Cardiol. doi: /nrcardio

Relapsed/Refractory Myeloma: Foundational Knowledge Essential to Improve Patient Outcomes.

Disease-specific survival

Hardeep Singh, Rachel Schiesser, Gobind Anand, Peter A

Kaplan–Meier curves of long-term survival in young (

Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a population-based cohort study K.O. Gradel, R.W. Thomsen, S.

Sarah A. Holstein, Paul G. Richardson, Jacob P. Laubach, Philip L

Adults with Health Problems Who Have an Excellent Patient Experience Report Greater Support to Help Manage Their Health Condition Percent of adults 18–64.

Comparison of clinical and functional parameters between the CMV+ and CMV− participants in the healthy elderly and elderly patients with T2DM. Comparison.

UK Renal Registry 14th Annual Report

Clinical Challenges in the Patient With Relapsed Multiple Myeloma

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Michelle Maria Pietzak Gastroenterology

Minimal Residual Disease and Hematologic Malignancies

Autonomic Tone and Benefits of Cardiac Rehabilitation Programs

Clinical Challenges in the Transplant-Eligible Patient With Newly Diagnosed Multiple Myeloma.

Figure 2. Associations of comorbidities with PD in elderly participants in the multivariate regression analysis. The multivariate Cox proportional-hazards.

Presentation transcript:

Managing Multiple Myeloma in the Elderly

Case 1 A 74-Year-Old Patient With Newly Diagnosed MM and Excellent Clinical Parameters (Karnofsky Score ≥ 80% and Charlson Score 0)

Case 2 A 74-Year-Old Patient With Newly Diagnosed MM and Good Clinical Parameters (Karnofsky Score of 60%-80% and Charlson Score ≤ 2)

Case 3 A 68-Year-Old Patient With Newly Diagnosed MM and Renal Insufficiency

Case 4 A 73-Year-Old Patient With Newly Diagnosed MM and a History of Cardiac Disease

Case 5 A 67-Year-Old Patient With Newly Diagnosed MM and Multiple Comorbidities

Case 6 A 79-Year-Old Patient With Relapsed/Refractory MM

Thank you for participating in this activity.